Ignite Creation Date:
2024-05-06 @ 5:55 PM
Last Modification Date:
2024-10-26 @ 2:37 PM
Study NCT ID:
NCT05470283
Status:
ACTIVE_NOT_RECRUITING
Last Update Posted:
2024-04-11
First Post:
2022-07-20
Brief Title:
Phase I Open-Label Study of Tumor Infiltrating Lymphocytes Engineered With Membrane Bound IL15 Plus Acetazolamide in Adult Patients With Metastatic Melanoma
Sponsor:
MD Anderson Cancer Center
Organization:
MD Anderson Cancer Center
Key Dates - Follows AllAPIJSON File Order
Start Date:
2022-09-07
Start Date Type:
ACTUAL
Primary Completion Date:
2027-04-01
Primary Completion Date Type:
ESTIMATED
Completion Date:
2027-04-01
Completion Date Type:
ESTIMATED
First Submit Date:
2022-07-20
First Submit QC Date:
July 20 2022
Study First Post Date:
2022-07-22
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2024-10-07
Last Update Post Date:
2024-04-11
Last Update Post Date Type:
ACTUAL